Symbols

PSTV

Plus Therapeutics·NASDAQ

--(--)

PSTV Profile

Plus Therapeutics, Inc.

A U.S. pharmaceutical company that develops innovative, targeted radiotherapeutics for cancers

Industry

Biological Technology

Established Date

Listing Date

12/19/2005

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.plustherapeutics.com

Security Type

Common stock

Office address

6420 Levit Green Boulevard, Suite 310, Houston, TX

Business

Introduction

Plus Therapeutics, Inc., was originally incorporated as a California general partnership in July 1996 and was incorporated in Delaware in May 1997. The Company is an American healthcare company focused on the development and commercialization of precise diagnosis and targeted radiopharmaceuticals for central nervous system (" CNS ") cancers. CNSide Diagnostics, LLC, its wholly-owned subsidiary, develops and commercializes proprietary laboratory-developed tests, such as CNSide, designed to identify tumor cells that have metastasized to the central nervous system in cancer and melanoma patients.